S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CLDX Celldex Therapeutics Inc

39.35

0.00 (0.00%)

Pre Market

Last Updated: 03:53:19

Delayed by 15 minutes

3 Experimental Cancer Drugs Investors Should Be Closely Watching

http://www.fool.com/investing/general/2015/07/02/3-experimental-cancer-drugs-investors-should-be-cl.aspx?source=eptadnlnk0000002

Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Celldex Therapeutics Charts.

Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Celldex Therapeutics Charts.

News

Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
Wednesday 17 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Celldex Therapeutics Announces Proposed Public Offering of Common Stock
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 26 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Monday 26 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 26 February 2024 (2 months ago) • Edgar (US Regulatory)

More News Articles

Global Developments (PK)

FBEC Worldwide (PK)

Mullen Automotive

Atacama Resources (PK)

NaturalShrimp (QB)

NioCorp Developments

Federal Home Loan Mortgage (QB)

Branded Legacy (PK)

MicroCloud Hologram

International Star (PK)

Fannie Mae (QB)

Tonner One World (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions